Regulatory Peptides

Location of immunoreactive sorbin in the digestive tract
pp. 1-1(1)
Authors: El Fadil F.A.; Nicol P.; Leduque P.; Whabi K.; Descroix-Vagne M.; Pansu D.

Transcriptional regulation of glucagon receptor gene expression by cAMP.
pp. 1-1(1)
Authors: Abrahamsen N.; Dichmann D.S.; Vissing H.; Nishimura E.

Regulatory peptides, reapplied sequences and related genes: functional inventiveness through genomic conservation in the evolutionary biology of the complex organisms.
pp. 2-2(1)
Author: Adelson J.W.

Marked gastrointestinal hormone surges accompany the massive bowel adaptation associated with feeding in the Burmese python.
pp. 2-2(1)
Authors: Adrian T.E.; Secor S.; Fehsenfeld D.; Staab P.; Diamond J.

Xanthines mediate the anti-proliferative effect of octreotide in MCF-7 human mammary carcinoma cells.
pp. 3-3(1)
Authors: Alperin-Lea R.; Redmann J.; Watson J.; Woltering E.

Pancreatic polypeptide (PP) immunodeficiency reproduces the altered hepatic glucose responses of chronic pancreatitis (CP)
pp. 3-3(1)
Authors: Andersen D.; Seymour N.; H C.W.; Ruiz C.; Hull E.; Dong X.; Burant C.; Walsh J.; Brunicardi F.

Calcitonin gene related peptide induction of interleukin 8 in human microvascular endothelial cells.
pp. 4-4(1)
Authors: Ansel J.A.; Song I.; Harten B.; Kramp J.M.; Armstrong C.A.; Bunnett N.W.

A population distribution study of lung and mid gut carcinoid patients over a twenty year period
pp. 4-4(1)
Authors: Ardill J.; McDevitt M.; Johnston C.; Buchanan K.

Evidence that gastrin can cross the placenta
pp. 5-5(1)
Authors: Ardill J.; McVeigh J.; Harper A.; Buchanan K.

A novel immortalized pancreatic acinar cell line: growth sensitivity to caerulein and growth factors
pp. 5-5(1)
Authors: Arita Y.; Douziech N.; Blouin R.; LeBel D.; Morisset J.

Plasma Cholecystokinin Levels in Patients with Pancreatic Exocrine Insufficiency
pp. 6-6(1)
Authors: Armstrong E.; Buchanan K.D.

Does IAPP play a physiological role in the control of food intake or glucose metabolism?
pp. 6-6(1)
Authors: Arnelo U.; Adrian T.; Permert J.; Larsson J.; Reidelberger R.

Is cyclic AMP involved in the contractile response of rainbow trout gastrointestinal smooth muscle to bombesin and trout gastrin releasing peptide?
pp. 7-7(1)
Authors: Aronsson U.; Jensen J.; Holmgren S.

Expression of reg gene and its product are enhanced in gastric endocrine cells aroud water immersion-induced gastric lesions in rat
pp. 7-7(1)
Authors: Asahara M.; Fukui K.; Kinoshita Y.; Kishi K.; Matsushima Y.; Fujita N.; Kawanami T.; Chiba T.

Gastrin receptor gene expression is increased in water immersion-induced gastric lesions in rat
pp. 8-8(1)
Authors: Asahara M.; Fukui K.; Kinoshita Y.; Kishi K.; Matsushima Y.; Kawanami T.; Chiba T.

Immunohistochemical investigations of the IGF-I receptors on the surface of ependymal cells of the hypothalamus median eminence
pp. 8-8(1)
Authors: Babichenko I.I.; Medvedev D.I.

Characterisation of a novel ligand for human CRH binding protein in sheep brain
pp. 9-9(1)
Authors: Baigent S.; Woods R.; Kemp F.; Lowry P.

Polyamines in the gastrointestinal tract
pp. 9-9(1)
Authors: Bardocz S.; Grant G.; Pusztai A.

Ontogenetic expression of WE-14 and chromogranin A in the rat neuroendocrine system.
pp. 10-10(1)
Authors: Barkatullah S.; Curry W.; Johnston C.; Hutton J.; Buchanan K.

Effect of oxyntomodulin and related peptides on the hydromineral transport through rat small intestine.
pp. 10-10(1)
Authors: Beauclair F.; Pansu D.; Rodier G.; Mochizuki T.; Martinez J.; Bataille D.; Jarrousse C.

Identification of the first non-peptide inverse agonist for a peptide hormone receptor: a prototype for a new class of drugs.
pp. 11-11(1)
Authors: Beinborn M.; Quinn S.M.; Kopin A.S.

A point mutation in the human CCK-B/gastrin receptor confers constitutive signaling activity.
pp. 11-11(1)
Authors: Beinborn M.; Wu M.-J.; Quinn S.M.; Goke E.-K.; Kolakowski L.F.; Kopin A.S.

Neural and hormonal regulation of exocrine pancreatic secretion: secretagogue specific changes in lectin binding to zymogen granules of pancreatic acinar cells.
pp. 12-12(1)
Authors: Bharwani S.; Coutu J.; Jeraldo T.; Adelson J.

Exocrine pancreatic secretion and gastrin release in response to ammonia
pp. 12-12(1)
Authors: Bilski J.; Jaworek J.; Cieszkowski M.; Bielanski W.; Konturek S.J.

Neuropeptide Y and chromogranin derived peptides in tumours of the sympathetic nervous system
pp. 13-13(1)
Authors: Bjellerup P.; Eder U.; Fischer-Colbrie R.; Theodorsson E.; Kogner P.

CCK-processing in porcine pituitary
pp. 13-13(1)
Authors: Blanke S.; Bundgaard J.; Sundler F.; Johnsen A.; Rehfeld J.

Arginine-vasopressin as target of angiotensin II in the brain in vitro.
pp. 14-14(1)
Authors: Blume A.; Georgakopoulos E.; Lebrun C.; Culman J.; Mollenhoff E.; Herdegen T.; Unger T.

Action of Glucagon-like Peptide-1 (7-36)amide (GLP-1) on Cytosolic Calcium in the -Cell Line INS-1
pp. 14-14(1)
Authors: Bode H.-P.; Goihl P.; Goke B.

Impact of Somatostatin Receptor Scintigraphy in Patients with Suspected Meningeoma
pp. 15-15(1)
Authors: Bohuslavizki K.H.; Brenner W.; Behnke A.; Tinnemeyer S.; Hugo H.-H.; Wolf H.; Clausen M.; Mehdorn H.M.; Henze E.

Novel GRP/CCK test evaluates antral D-G cell interaction and parietal cell secretion in H.P.-positive duodenal ulcer patients. Role of antral gastritis.
pp. 15-15(1)
Authors: Bojko J.B.; Burlage M.; Erdag S.; Nustede R.; Stolte H.; Folsch U.R.; Schmidt W.E.

Alterations in gastrin cells induced by short-term omeprazole treatment in the rat antrum: an immunocytochemical and in situ hybridization study.
pp. 16-16(1)
Authors: Bolkent S.; Yilmazer S.

Characterization of chimeric glucose-dependent insulinotropic polypeptide (GIP) and glucagonlike peptide-1 (GLP-1) receptor proteins.
pp. 16-16(1)
Authors: Boylan M.O.; Jepeal L.I.; Wolfe M.M.

The differing endocrinology of mid gut and lung neuroendocrine tumours
pp. 17-17(1)
Authors: Buchanan K.D.; Johnston C.F.; Shaw C.

Structural requirements for tyrosine sulfation of progastrin and its biological effects
pp. 17-17(1)
Authors: Bundgaard J.R.; Vuust J.; Rehfeld J.F.

Trafficking of the receptor for gastrin releasing peptide in swiss 3T3 cells after exposure to agonist
pp. 18-18(1)
Authors: Bunnett N.W.; Dulai G.; Slice L.; Walsh J.H.; Grady E.F.

Central Nervous System Effects of PACAP 1-38 on Gastrointestinal Transit in the Rat
pp. 18-18(1)
Authors: Burlage M.; Folsch U.R.; Schmidt W.E.

Inhibitory effects of hyperglycemia and hyperinsulinemia on postprandial human jejunal motility
pp. 19-19(1)
Authors: Byrne M.; Pluntke K.; Arnold R.; Goke B.; Schirra J.; Katschinski M.

Apparent 'gain-of-function' without actual increase in real binding affinity or potency in Mapping of ligand binding sites in the NK-1 receptor
pp. 19-19(1)
Authors: Cahir M.; Rosenkilde M.M.; Schwartz T.W.

Responses of canine gastric G- and D- cells in primary culture to cytokines and Helicobacter pylori products
pp. 20-20(1)
Authors: Calam J.; Beales I.; DelValle J.

Adrenomedullin-(22-52) antagonizes vasodilator responses to calcitonin gene-related peptide but not adrenomedullin in the cat
pp. 20-20(1)
Authors: Champion H.C.; Santiago J.A.; McNamara D.B.; Murphy W.A.; Coy D.H.; Kadowitz P.J.

Cellular mechanism of L-tryptophan-stimulated cholecystokinin secretion.
pp. 21-21(1)
Authors: C. H.L.C.; W. Y.C.; Coy D.H.; T.-M. C.

Neuropeptide modulation of secretin secretion from secretin producing cells.
pp. 21-21(1)
Authors: C. H.L.C.; W. Y.C.; Coy D.H.; T.-M. C.

Purification of two secretin releasing factors from canine pancreatic juice.
pp. 22-22(1)
Authors: T.-M. C.; K. Y.L.; C. H.L.C.; P. L.; Y. S.; W. Y.C.

Trophic Effects of Gastrointestinal Surgery on Rat Pancreas
pp. 22-22(1)
Authors: Duan C.; Kimura K.; Yamada H.; Nylander A.-G.; Norlen P.; Hakanson R.

Impaired formation and accelerated resorption of bone after gastrectomy. No association with circulating CA²⁺, parathyroid hormone, calcitonin and gastrin.
pp. 23-23(1)
Authors: Chen D.; Muhlbauer R.C.; Wang J.-S.; Schenk R.K.; Lehto-Axtelius D.; Aspenberg P.; Hakanson R.

Growth-promoting effects of endogenous gastrin
pp. 23-23(1)
Authors: Duan C.; Nylander A.-G.; Hakanson R.

The gastrin-ECL cell axis: gastrin induces secretion, activation and adaptation of ECL cells in rats
pp. 24-24(1)
Authors: Duan C.; Chun-Mei Z.; Norlen P.; Hakanson R.

Induction of apoptosis in mucosa lymphocytes blocks secretion of gastric acid stimulated by gastrin and histamine in rat.
pp. 24-24(1)
Authors: Xue-qing C.; Yu-gang S.; Tian-mo W.; Wan-dai Z.; Dian-yuan Z.

Do gut peptides contribute to liver fibrosis? - Evidences that vasoactive intestinal peptide affects collagen secretion by rat lipocytes.
pp. 25-25(1)
Authors: Y.J. C.; Y.F. C.

The influence of somatostatin on the deafferented amygdalar neurons (microiontophoretical study)
pp. 25-25(1)
Authors: Chepurnova N.E.; Titova A.V.; Chepurnov S.A.

Distinct actions of gastrin on parietal and enterochromaffin-like cells of mastomys natalensis.
pp. 26-26(1)
Authors: Chiba T.; Kinoshita Y.; Nakata H.; Inomoto Y.; Asahara M.; Kawanami C.; Matsushima Y.; Kishi K.

Increased sensitivity of rat exocrine pancreas to intake of high levels of dietary fat.
pp. 26-26(1)
Authors: Chowdhury P.; Blevins G.; Rayford P.L.

Cooperation of and adrenergic agonists in the control of ileal endocrine secretions from the isolated vascularly perfused rat ileum.
pp. 27-27(1)
Authors: Claustre J.; Brechet S.; Dumoulin V.; Chayvialle J.A.; Cuber J.C.

Both colonic and gastric smooth muscle cells in the guinea pig express somatostatin (SS) receptor subtypes 2, 3, and 5.
pp. 27-27(1)
Authors: Corleto V.D.; Jensen R.T.; Weber H.C.

Influence of pentagastrin on immunitory system (preliminary report).
pp. 28-28(1)
Authors: Coulic V.; Cosyn J.-P.; Alewaeters A.

5-HT₁ receptor activation by sumatriptan inhibits gastrointestinal and pancreatic hormone secretion in man.
pp. 28-28(1)
Authors: Coulie B.; Tack J.; Bouillon R.; Peeters T.L.; Janssens J.

Transcriptional regulation of the VIP 1 receptor mRNA during enterocytic differentiation of human colon cancer cells, Caco-2.
pp. 29-29(1)
Authors: Couvineau A.; Maoret J.; Carrero I.; Rouyer-Fessard C.; Laburthe M.

Immunoreactivity to a fragment of vasostatin I in human ileal carcinoids.
pp. 29-29(1)
Authors: Cunningham R.T.; Curry W.J.; Johnston C.F.; Buchanan K.D.

GLP-1 release from canine L-cells is regulated by GIP, but not by glucose.
pp. 30-30(1)
Authors: Damholt A.B.; Buchan A.M.J.; Kofod H.

Dipeptidyl peptidase IV inhibition influences GLP-1 metabolism in vivo
pp. 30-30(1)
Authors: Deacon C.F.; Pridal L.; Olesen M.; Klarskov L.; Holst J.J.

Sequence of a cDNA encoding for the motilin precursor in sheep.
pp. 31-31(1)
Authors: De Clercq P.; Svoboda M.; Peeters T.L.

The sst2 somatostatin receptor subtype is a tumor suppressor gene.
pp. 31-31(1)
Authors: Delesque N.; Buscail L.; Esteve J.P.; Rauly I.; Saint-Laurent N.; Muller C.; Capella G.; Weckbecker G.; Bruns C.; Vaysse N.; Susini C.

Differential expression of vasoactive intestinal peptide receptors (VIP-R1 and VIP-R2) mRNA in murine lymphpocytes.
pp. 32-32(1)
Authors: Delgado M.; Martinez C.; Johnson M.C.; Gomariz R.P.; Ganea D.

Distribution and subcellular localization of motilin receptor sites in the rabbit cerebellum.
pp. 32-32(1)
Authors: Depoortere I.; Peeters T.

The isolation and sequencing of cDNA encoding for the motilin precursor from rabbit and human brain, suggests a neuromodulatory role for motilin
pp. 33-33(1)
Authors: Depoortere I.; Peeters T.L.; De Clercq P.; Svoboda M.

Two peptides derived from the nerve growth factor precursor are expressed predominantly in the rat intestine
pp. 33-33(1)
Authors: Dicou E.; Nerriere V.; Lebraud V.; Lehy T.

Is there another mechanism of action related to D-2 dopamine receptors
pp. 34-34(1)
Authors: Diculescu M.; Iov A.; Oproiu A.

Differential distribution, and expression of GATA transcription factors in rat stomach during development and in response to feeding
pp. 34-34(1)
Authors: Dimaline R.; Campbell B.J.; Struthers J.; Sandvik A.K.; Noble P.-J.

Evaluation of the Specificity and Potency of a Series of Cholecystokinin-B/Gastrin Receptor Antagonists in Vivo
pp. 35-35(1)
Authors: Xi-Qin D.; Hakanson R.

Tumor necrosis factor stimulates amylin secretion but inhibits insulin from islet -cells by independent pathways
pp. 35-35(1)
Authors: Ding X.-Z.; Flatt P.R.; Adrian T.E.

Pancreatic cancer cells secrete a factor that selectively stimulates amylin secretion from -islet cells
pp. 36-36(1)
Authors: Ding Z.; Flatt P.R.; Permert J.; Adrian T.E.

Are CCK-8 effects on food-intake mediated via direct access to the brain
pp. 36-36(1)
Authors: Drewe J.; Huwyler J.; Fricker G.; Behrens U.; Beglinger C.

Therapy of carcinoid with somatostatin and intraarterial chemoembolization (IACTH)
pp. 37-37(1)
Authors: Drezgic M.; Nesovic M.; Vujovic S.; Radojkovic S.; Tazev S.; Colovic R.

Aspartate 196 in the first extracellular loop of the human vasoactive intestinal peptide (VIP) 1 receptor is involved in VIP binding
pp. 37-37(1)
Authors: Kai D.; Nicole P.; Couvineau A.; Laburthe M.

Regulation of gut motility by Leu-callatostatins, a family of insect brain/gut peptides with possible vertebrate homologues
pp. 38-38(1)
Authors: Duve H.; Johnsen A.H.; East P.D.; Maestro J.-L.; Scott A.G.; Thorpe A.

Feeding-dependent regulation of the yolk protein genes in the fruitfly, drosophila melanogaster
pp. 38-38(1)
Authors: Egetoft P.; Sondergaard L.

Expression and Activity of MAP Kinases in Colonic and Gastric Carcinomas
pp. 39-39(1)
Authors: Eggstein S.; Franke M.; Kutschka I.; Manthey G.; Specht B.-U.v.; Farthmann E.H.

Vasoactive intestinal peptide expression in enteric neurons is upregulated by both colchicine and axotomy
pp. 39-39(1)
Authors: Ekblad E.; Mulder H.; Sundler F.

Connectivity and rotation of transmembrane helices in 7TM receptors probed by metal-ion site engineering
pp. 40-40(1)
Authors: Elling C.E.; Schwartz T.W.

Isolation and characterization of a novel intestinal peptide
pp. 40-40(1)
Authors: Ensinck J.; Vogel R.; Laschansky E.; Francis B.; Baskin D.; D'Alessio D.

PACAP innervation of the rat female reproductive tract and the associated paracervical ganglia: effect of capsaicin
pp. 41-41(1)
Authors: Fahrenkrug J.; Hannibal J.

An improved microassay for simultaneous measurement of cholecystokinin receptor binding and amylase secretion in dispersed pancreatic acini
pp. 41-41(1)
Authors: Fehsenfeld D.; Adrian T.

Simultaneous measurement of devazepide and cholecystokinin in plasma
pp. 42-42(1)
Authors: Fehsenfeld D.; Adrian T.

Receptor subtypes and effects of somatostatin in human brain tumors compared to normal brain cells
pp. 42-42(1)
Authors: Feindt J.; Christofides C.; Krisch B.; Mentlein R.

Distribution of nitric oxide synthase and vasoactive intestinal polypeptide in the developing human fetal ileocecal junction
pp. 43-43(1)
Authors: Fekete E.; Timmermans J.-P.; Resch B.A.; Scheuermann D.W.

Effect of exercise and -blockade on xenin plasma concentrations
pp. 43-43(1)
Authors: Feurle G.E.; Hanhart N.; Hamscher G.

Spontaneous plasma extravasation in neutral endopeptidase (NEP) knockout mice is mediated by substance P (SP) and bradykinin (BK)
pp. 44-44(1)
Authors: Figini M.; Emanueli C.; Grady E.F.; Geppetti P.; Kirkwood K.; Ansel J.C.; Payan D.G.; Gerard C.; Bunnett N.W.

Effects of NPY on duodenal mucosal alkaline secretion and motility
pp. 44-44(1)
Authors: Flemstrom G.; Nylander O.; Larhammar D.

Interleukin induced Gastrin Release in a Polarized Organ Culture of Porcine Antrum
pp. 45-45(1)
Authors: Flesch I.; Weinmann I.; Teichmann R.; Becker H.D.

Effect of Sodium Pentobarbital Anaesthesia on Rat Tissue and Mast Cell Histamine
pp. 45-45(1)
Authors: Flesch I.; Williams R.; Stead R.

Different distribution of PACAP and VIP immunoreactivities in hypothalamic magnocellular cell groups and in the posterior pituitary of rats and cats
pp. 46-46(1)
Authors: Fogel K.; Kausz M.; Lakatos A.; Gorcs T.; Arimura A.; Koves K.

C-type natriuretic peptide (CNP) alters effects of gonadotropin-releasing hormone (GnRH) on Ca²⁺ in T3-1 cells but does not alter the effect of GnRH on cytosolic Ca²⁺ or LH secretion from rat pituitary cells.
pp. 46-46(1)
Authors: Fowkes R.C.; Forrest-Owen W.; McArdle C.A.

PACAP and VIP in canine ileum: immunohistochemical, binding and functional studies.
pp. 47-47(1)
Authors: Fox-Threlkeld J.E.T.; Mao Y.K.; Cayabyab F.S.; Y. F.W.; S. L.; Daniel E.E.; McDonald T.J.

Pituitary adenylate cyclase activating peptide (PACAP) is better than vasoactive intestinal peptide (VIP) in enhancing [³H]acetylcholine (ACH) release from nerve endings in canine ileal circular muscle (CM) and inducing CM motor activity in vivo.
pp. 47-47(1)
Authors: Fox-Threlkeld J.-A.E.T.; Woskowska Z.; Daniel E.E.

Generation of Gastrin Deficient Mice.
pp. 48-48(1)
Authors: Friis-Hansen L.; Rourke I.J.; Gillespie P.J.; Saunders T.L.; Rehfeld J.F.; Samuelson L.C.

Effect of PACAP 38, PACAP 27, VIP and CCK on the release of serotonin from isolated vascularly and luminally perfused rat duodenum
pp. 48-48(1)
Authors: Fujimiya M.; Kuwahara A.

Distribution of neuropeptide Y-immunoreactive nerves in hepatolithiasis
pp. 49-49(1)
Authors: Fujimura M.; Kinoshita T.; Yamamoto I.

Characterization of a constitutively active mutant of the human vasoactive intestinal peptide (VIP) 1 receptor
pp. 49-49(1)
Authors: Gaudin P.; Rouyer-Fessard C.; Couvineau A.; Maoret J.-J.; Laburthe M.

Thymic T-cell education to neuroendocrine-related self-antigens: physiological implications in T-cell life and death
pp. 50-50(1)
Authors: Geenen V.; Achour I.; Kecha O.; Vandersmissen E.; Martens H.

Expression Cloning of a Human Brain Neuropeptide Y Y2 Receptor.
pp. 50-50(1)
Authors: Gehlert D.R.; Beavers L.; Johnson D.; Gackenheimer S.L.; Schober D.A.; Gadski R.A.

The carboxy-terminal tail length of the rat islet glucose-dependent insulinotropic polypeptide is important for efficient expression at the membrane level, and activation of adenylyl cyclase.
pp. 51-51(1)
Authors: Gelling R.W.; Yan W.; Su R.-C.; Mathi S.K.; Gyomorey S.; Pederson R.A.; McIntosh C.H.S.; Wheeler M.B.

Molecular Biology and Pharmacology of NPY/PYY/PP Receptors: How Many More Subtypes?
pp. 51-51(1)
Authors: Gerald C.; Walker M.W.; Smith K.E.; Vaysse P.J.-J.; Branchek T.A.; Weinshank R.L.

Adrenomedullin-a novel vasodilator peptide distribution of receptors and immunoreactivity in the rat
pp. 52-52(1)
Authors: Ghatei M.A.; Smith D.M.; Owji A.A.; Upton P.D.; Bloom S.R.

Importance of the vagus nerves in duodenal acid neutralization in anaesthetized pigs.
pp. 52-52(1)
Authors: Glad H.; Svendsen P.; Schaffalitzky de Muckadell O.B.

Substance P and NADPH diaphorase in cardiac ganglia on early stage of cardiomyopathy.
pp. 53-53(1)
Authors: Goncharuk V.D.; Khatkievich A.N.; Okhotin V.Y.

Gastrin and Gastrin Receptor Gene Expression in Pancreatic Cancer: Evidence for Autocrine Growth Stimulation.
pp. 53-53(1)
Authors: Gotze J.P.; Nielsen F.C.; Lam G.; Burcharth F.; Rehfeld J.F.

The C-terminal half of secretin and VIP interacts with the N-terminal domain of their receptors.
pp. 54-54(1)
Authors: Gourlet P.; Vandermeers A.; Vandermeers-Piret M.-C.; Waelbroeck M.; Robberecht P.

Plasma chromogranin a as a marker of endocrine pancreatic tumors in multiple endocrine neoplasia type 1.
pp. 54-54(1)
Authors: Granberg D.; Stridsberg M.; Oberg K.; Seensalu R.; Eriksson B.; Skogseid B.

Transient expression of PACAP in steroidogenic cells of the rat ovary.
pp. 55-55(1)
Authors: Gras S.; Hannibal J.; Georg B.; Fahrenkrug J.

Biosynthesis of neuropeptides in cnidarians: Novel mechanisms in preprohormone processing.
pp. 55-55(1)
Author: Grimmelikhuijzen C.J.P.

Glucagon-like peptide 1 stimulates exocytosis in mouse pancreatic B-cells through protein kinase A and protein kinase C dependent mechanism.
pp. 56-56(1)
Authors: Gromada J.; Ding W.; Renstrom E.; Rorsman P.

Effects of glucagon and glucagon-like peptide-1 (7-36) amide (tGLP-1) on C-cells from rat thyroid and medullary thyroid carcinoma CA-77 cell line.
pp. 56-56(1)
Authors: Gros L.; Crespel A.; de Boisvilliers F.; Kervran A.

Chimeric neuropeptide Y-peptide YY peptides act at Y3 receptors to suppress synaptic transmission in the rat nucleus of the solitary tract
pp. 57-57(1)
Authors: Grundemar L.; Miller R.J.; Rhim H.; Maclean D.; Georgic L.M.; MacKenzie R.G.; Glaum S.R.

Role of neurofibromin 1 (NF1) in signal transduction mediating PACAP-like neuropeptide response.
pp. 57-57(1)
Authors: Feifu G.; Inge T.; Bernards A.; Hariharan I.; Yi Z.

Insulin-like growth factor-1 promotes drug resistance and expression of c-H-ras and P-glycoprotein in MCLM colon cancer cells.
pp. 58-58(1)
Authors: Yan-Shi G.; Gui-Fang J.; Houston C.W.; Thompson J.C.; Townsend C.M.

CCK-8 and gastrin induced ERK1 and ERK2 mediated c-fos transcription and activation of the transcription factor complex AP-1 in rat pancreatic AR42J cells.
pp. 58-58(1)
Authors: Gunther R.; Gundlach F.; Bauer I.; Schmidt W.E.

Vasoactive intestinal peptide (VIP): a paracrine messenger in the human adrenal
pp. 59-59(1)
Authors: Haidan A.; Bornstein S.R.; Glasow A.; Dieterich F.; Waterman M.; Scherbaum W.A.; Ehrhart-Bornstein M.

Proxenin, a peptide precursor of xenin with a highly conserved amino acid sequence during evolution from yeast to mammals
pp. 59-59(1)
Authors: Hamscher G.; Meyer H.E.; Feurle G.E.

Prognostic factors in medullary carcinoma of the thyroid
pp. 60-60(1)
Authors: Hanna F.; Cunningham R.; Ardill J.; Johnston C.; Russell C.; Buchanan K.

Effects of extrinsic denervation or capsaicin on PACAP innervation of the rat gastrointestinal tract.
pp. 60-60(1)
Authors: Hannibal J.; Ekblad E.; Mulder H.; Sundler F.; Fahrenkrug J.

'Steric hindrance' mutagenesis versus 'Ala-scan' in mutational mapping of binding sites in 7TM receptors
pp. 61-61(1)
Authors: Hansen B.H.; Zoffman S.; Schwartz T.W.

Somatostatin is a major, paracrine regulator of glucagon-like peptide-1 (GLP-1) secretion in isolated perfused porcine ileum.
pp. 61-61(1)
Authors: Hansen L.; Mineo H.; Bisgaard T.; Jorgensen P.N.; Holst J.J.

Signalling pathways activated by the cloned human glucagon receptor expressed in BHK cells.
pp. 62-62(1)
Authors: Hansen L.H.; Whitmore T.; Bouchelouche P.; Kindsvogel W.; Nishimura E.

Synergistic effects of growth factors and cAMP on regulation of the human cholecystokinin gene activity mediated through a CRE/TRE element.
pp. 62-62(1)
Authors: Hansen T.v.O.; Nielsen F.C.; Bundgaard J.R.; Rehfeld J.F.

Enrichment of gastric endocrine cells by continuous immuno magnetic separation
pp. 63-63(1)
Authors: Hartig R.; Liebich H.; Teichmann R.; Saalmuller A.; Becker H.

Structure, analysis and secretion of human glucagon-like peptide-2 (GLP-2).
pp. 63-63(1)
Authors: Hartmann B.; Johnsen A.H.; Orskov C.; Holst J.J.

Gut hormone release in gastrectomised dogs, after sucrose loading with or without a-glucosidase inhibitor.
pp. 64-64(1)
Authors: Hasegawa S.; Kameyama J.-i.; Matsumoto O.; Tsukamoto M.; Manaka H.; Sasaki H.

Molecular cloning, genomic organization and developemental regulation of a novel Drosophila receptor structurally related to members of the TSH, FSH, LH/CG receptor family from mammals
pp. 64-64(1)
Authors: Hauser F.; Nothacker H.-P.; Grimmelikhuijzen C.J.P.

Evidence that the N-terminal domain of the GLP-I receptor contains amino acids crucial for GLP-I binding
pp. 65-65(1)
Authors: Hedetoft C.; van Eyll B.; Wilmen A.; Hareter A.; Goke B.; Goke R.

Calcitonin gene related peptide is an important secretagogue for rat intestinal L-cells
pp. 65-65(1)
Authors: Herrmann-Rinke C.; Arnold R.; Goke B.

Diazepam binding inhibitor stimulates cholecystokinin release by cAMP- and Ca-dependent mechanisms from STC-1 cells
pp. 66-66(1)
Authors: Herzig K.H.; Brunke G.; Kiehne K.; Tatemoto K.; Folsch U.R.

Effect of somatostatin, peptide YY and taurocholate on diazepam binding inhibitor stimulated cholecystokinin release from isolated intestinal mucosal cells
pp. 66-66(1)
Authors: Herzig K.H.; Wilgus C.; Tatemoto K.; Folsch U.R.

GCAP-II: Isolation and Characterization of a New Guanylate Cyclase C Activating Peptide from Human Blood
pp. 67-67(1)
Authors: Hess R.; Kuhn M.; Fuchs M.; Klodt J.; Cetin Y.; Schulz-Knappe P.; Raida M.; Adermann K.; Forssmann W.G.

Generation of a tripeptoid library (oligo N-substituted glycines) for the discovery of ligands for the bombesin/GRP receptor
pp. 67-67(1)
Authors: Hildebrand P.; Heizmann G.; Ketterer S.; Tanner H.; Eberle A.N.; Beglinger C.

Screening for signal transduction through the Jak/STAT pathway in response to G-protein-coupled receptor stimulation
pp. 68-68(1)
Authors: Hildebrand P.; Pansky A.; Heim M.; Beglinger C.

Structure and expression pattern of the human guanylyl cyclase activating peptide II gene (GCAP-II, uroguanylin)
pp. 68-68(1)
Authors: Hill O.; Cieslak A.; Fuchs M.; Forssmann W.G.; Magert H.J.

Post-translational processing of human chromogranin B is tissue-specific.
pp. 69-69(1)
Authors: Hilsted L.; Jensen T.B.; Gustafsen J.; Knigge U.; Orskov C.; Rehfeld J.F.

Pancreatic endocrine function and glucagon-like peptide-1 levels in patients after pylorus preserving pancreatoduodenectomy.
pp. 69-69(1)
Authors: Hiroyoshi M.; Tateishi K.; Yasunami Y.; Ikeda S.; Matsuoka Y.

Natriuretic peptides inhibit A K⁺ conductance in immortalized human kidney epithelial cells (IHKE-1).
pp. 70-70(1)
Authors: Hirsch J.R.; Kruhoffer M.; Meyer M.; Forssmann W.-G.; Mollerup S.; Cermak R.; Ankorina-Stark I.; Weber G.; Schlatter E.

'Two-domain structure of the Glucagon Receptor: peptide binding and signal transduction'
pp. 70-70(1)
Authors: Hjorth S.A.; Orskov C.; Schwartz T.W.

Immunological studies employing antisera generated to residues 120-143 of bovine chromogranin A
pp. 71-71(1)
Authors: Hogg R.B.; Curry W.J.; Johnston C.F.; Bader M.-F.; Aunis D.; Buchanan K.D.

Progastrin-derived peptides act as autocrine growth factors in the mouse colon cell line YAMC.
pp. 71-71(1)
Authors: Hollande F.; Imdahl A.; Agnew H.; Ciccotosto G.D.; Shulkes A.; Baldwin G.S.

Plasma PYY in response to intraduodenal amino acids with or without cholestyramine; role of cholecystokin.
pp. 72-72(1)
Authors: Hopman W.P.M.; Thimister P.W.L.; Maas M.I.M.; van Battum P.L.H.; Jansen J.B.M.J.

Plasma peptide YY in patients with proctocolectomy and ileal pouch-anal anastomosis; relation with plasma cholecystokinin.
pp. 72-72(1)
Authors: Hopman W.P.M.; van Battum P.L.H.; Salemans J.M.J.I.; Kuijpers H.J.H.; Nagengast F.M.; Jansen J.B.M.J.

In vivo influence of transforming growth factor on epithelial cell proliferation in digestive tissues of suckling rat
pp. 73-73(1)
Authors: Hormi K.; Lebraud V.; Lewin M.; Lehy T.

Neurotensin and postprandial regulation of the lower esophageal sphincter pressure
pp. 73-73(1)
Authors: Horstmann O.; Nustede R.; Lepsien G.; Becker H.

Diagnosis and treatment of zollinger-ellison syndrome /ZES/ in Slovakia
pp. 74-74(1)
Authors: Hyrdel R.; Beseda O.; Reznak I.; Kovacik O.; Straka V.

Interferon-alpha induces BCL-2 photo-oncogene in patients with neuroendocrine gut tumor responding to the antitumor action of the drug.
pp. 74-74(1)
Authors: Hassan I.; Barbro E.; Kjell O.

Respiratory and circulatory effects of opioid peptides microinjected into the solitary tract nucleus
pp. 75-75(1)
Authors: Inyushkin A.N.; Chepurnov S.A.; Merkulova N.A.

Secretin-stimulated bicarbonate secretion in interlobular ducts isolated from guinea-pig pancreas.
pp. 75-75(1)
Authors: Ishiguro H.; Naruse S.; Kitagawa M.; Hayakawa T.; Steward M.C.; Case R.M.

Effect of nonpeptide neurotensin receptor antagonist (SR48692) on growth of mouse small intestine.
pp. 76-76(1)
Authors: Iwase K.; Evers B.M.; Higashide S.; Hellmich M.R.; Townsend C.M.

Unusual clinical courses of gastrinoma.
pp. 76-76(1)
Authors: Jablonska M.; Hyrdel R.

Calcitonin gene-related peptide in the protection of pancreatic secretory function in course of acute pancreatitis
pp. 77-77(1)
Authors: Jaworek J.; Bilski J.; Konturek S.J.

Total chromogranin a as marker of carcinoid tumors.
pp. 77-77(1)
Authors: Jensen T.B.; Hilsted L.; Gustafsen J.; Knigge U.; Astrup L.; Rehfeld J.F.

Tissue specific processing of human chromogranin a.
pp. 78-78(1)
Authors: Jensen T.B.; Orskov C.; Hilsted L.; Paloheimo L.; Rehfeld J.F.

The biological behaviour of colorectal carcinoma cell line(HT-29) transfected with sense and antisense TGF- 1 gene in vitro.
pp. 79-79(1)
Authors: Jiang B.; Zhou D.; Chang H.; Chou T.

Characterization of the inhibitory effects of colorectal carcinoma cells transduced with gene for transforming growth factor 1.
pp. 79-79(1)
Authors: Jiang B.; Zhou D.; Chang H.; Zhou T.

A new pituitary protein inhibiting cholera toxin-activity in small intestine
pp. 80-80(1)
Authors: Johansson E.; Lonnroth I.; Lange S.; Jennische E.; Jonson I.; Lonnroth C.

Guanylin modulates the regulated secretion of the intestinal neuroendocrine cell line BON
pp. 80-80(1)
Authors: John M.; Kuhn M.; Kruhoffer M.; Forssmann W.G.; Riecken E.O.; Wiedenmann B.

More to the evolution of the cholecystokinin/gastrin family: Identification of CCK in a cartilaginous fish, the mackerel shark (Lamna cornubica)
pp. 81-81(1)
Author: Johnsen A.H.

Molecular cloning and expression of cholecystokinin and gastrin in some lower vertebrate species
pp. 81-81(1)
Authors: Jonson L.; Johnsen A.H.; Moller M.; Bundgaard J.R.; Rehfeld J.F.; Rourke I.J.

Cholecystokinin release by lectins; evidence for involvement of N-acetyl galactosamine (GalNAc) residues.
pp. 82-82(1)
Authors: Jordinson M.; Calam J.

CCK receptor antagonists possess intrinsic biologic activity that counteracts CCK agonist activity.
pp. 82-82(1)
Authors: Joshi S.N.; Z. Q.X.; Al-Shaher O.M.; Wank S.A.; Gardner J.D.

Differential regulation of CCK-A and CCK-B receptors by G protein activation.
pp. 83-83(1)
Authors: Joshi S.N.; Z. Q.X.; Al-Shaher O.M.; Wank S.A.; Gardner J.D.

State-specific, differential amplification of signal transduction by CCK and gastrin acting on CCK-B receptors.
pp. 83-83(1)
Authors: Joshi S.N.; Z. Q.X.; Al-Shaher O.M.; Wank S.A.; Gardner J.D.

Proadrenomedullin NH₂-terminal 20 peptide, a product of the adrenomedullin gene, has direct vasodilator activity in the cat
pp. 84-84(1)
Authors: Kadowitz P.J.; Murphy W.A.; Coy D.H.; McNamara D.B.; Champion H.C.

Inhibitory effect of galanin(1-15)ol analogs on neurally-evoked circular muscle contraction in the guinea-pig ileum.
pp. 84-84(1)
Authors: Kakuyama H.; Kuwahara A.; Mochizuki T.; Hoshino M.; Yanaihara N.

Dalargin (synthetic analog of Leu-enkephalin) effect on the bound Ca²⁺ amount in the neurons of rat embryo dissociated cultures of spinal cord.
pp. 85-85(1)
Author: Kalentchouk V.U.

Guanylin and its receptor (guanylyl cyclase C): expression and cell specific localization in the gastrointestinal tract
pp. 85-85(1)
Authors: Kampf U.; Kruhoffer M.; Bargsten G.; Grube D.; Forssmann W.G.; Cetin Y.

PACAP blocks the ovulation in rat administered icv before the critical period of proestrous stage
pp. 86-86(1)
Authors: Kantor O.; Molnar J.; Gorcs T.J.; Somogyvari-Vigh A.; Furst Z.; Arimura A.; Koves K.

Recovery and characterization of substance P endopeptidase activity in the rat spinal cord.
pp. 86-86(1)
Authors: Karlsson K.; Eriksson U.; Andren P.; Nyberg F.

Effects of short term parenteral nutrition on basal and stimulated gastric and exocrine pancreatic secretion.
pp. 87-87(1)
Authors: Karlsson L.; Sorhede M.; Erlanson-Albertsson C.; Zabielski R.; Pierzynowski S.G.

Differential CCK-mediated and cholinergic regulation of postprandial human jejunal motility.
pp. 87-87(1)
Authors: Katschinski M.; Boker K.; Wank U.; Arnold R.; Goke B.; Schirra J.

Identification of two amino-acids of the CCK-A receptor which are involved in the binding of the C-terminal nonapeptide of CCK
pp. 88-88(1)
Authors: Kennedy K.; Gigoux V.; Escrieut C.; Maigret B.; Bastie M.J.; Martinez J.; Moroder L.; Gully D.; Vaysse N.; Fourmy D.

Glucagon receptors on pancreatic -cells.
pp. 88-88(1)
Authors: Kieffer T.J.; Heller R.S.; Habener J.F.

The Response to Sustained Hypergastrinemia of the Individual ECL Cell.
pp. 89-89(1)
Authors: Kimura K.; Duan C.; Lindstrom E.; Yamada H.; Chun-Mei Z.; Hakanson R.

Innervation of the biliary ducts in humans, pigs and monkeys
pp. 89-89(1)
Authors: Kinoshita T.; Fujimura M.

Efects of a new gastrin/CCK-B receptor antagonist AG-041r on ECL carcinoid tumor cells of mastomys natalensis.
pp. 90-90(1)
Authors: Kinoshita Y.; Nakata H.; Asahara M.; Kawanami C.; Matsushima Y.; Kishi K.; Hoshino E.; Baba A.; Chiba T.

Substance P (SP) gene expression and colonic inflammation in DSS-colitic rats
pp. 90-90(1)
Authors: Kishimoto S.; Hayashi K.; Tawara Y.

Evidence that PC2 is the endogenous pro-neurotensin convertase in rMTC 6-23 cells and that PC1- and PC2-transfected PC12 cells differentially process pro-neurotensin with intestinal and brain phenotypes, respectively
pp. 91-91(1)
Authors: Kitabgi P.; Rovere C.; Barbero P.; Lafortune L.; Beaudet A.

Impaired processing of brain pro-neurotensin and pro-melanin-concentrating hormone in obese fat/fat mice
pp. 91-91(1)
Authors: Kitabgi P.; Rovere C.; Viale A.; Nahon J.-L.

Multi-signal cell regulation in gut
pp. 92-92(1)
Authors: Klimov P.K.; Barashkova G.M.; Zamyatnin A.A.

Aib⁸-Glucagon-Like Peptide-1 - an analog of GLP-1 with improved receptor affinity and metabolic stability.
pp. 92-92(1)
Authors: Knudsen L.B.; Nielsen P.F.; Adelhorst K.; Kirk O.; Wulff B.S.

Structure and function studies of the human VIP receptor 1
pp. 93-93(1)
Authors: Knudsen S.M.; Tams J.W.; Wulff B.S.; Fahrenkrug J.

Some Neuropeptides Control Activities of Pacemaker Nodule in the Guinea-Pig Colon
pp. 93-93(1)
Authors: Kobayashi S.; Iino S.

Glutathione is a neuroprotectant in the colon of the mouse.
pp. 94-94(1)
Authors: Koch T.R.; Ruan E.; Fink J.G.; Petro A.; Opara E.C.

Calcitonin gene-related peptide (GCRP) in ethanol treated and protein deficient rats
pp. 94-94(1)
Authors: Koko V.; Todorovic V.; Glisic R.

Effect of intragastric administration with -endorphin on gastric mucosal thyrotropin-releasing hormone (TRH) and somatostatin release in rats.
pp. 95-95(1)
Authors: Konagaya T.; Kusugami K.; Kaneko H.; Yamamoto H.; Nagai H.; Mitsuma T.

Effect of cholecystokinin and its receptor antagonists on the growth of human immortalized hepatocytes and hepatoma cells.
pp. 95-95(1)
Authors: Y. G.K.; Y. F.C.; Z. T.S.

Eradication of helicobacter pylori (Hp) and gastrin-somatostatin (S-S) link in duodenal ulcer (DU) patients.
pp. 96-96(1)
Authors: Konturek J.W.; Bielanski W.; Konturek S.J.; Domschke W.

Species differences in the CCK-B/gastrin receptor alter drug efficacy: implications for preclinical testing.
pp. 96-96(1)
Authors: Kopin A.S.; Gordon M.C.; McBride E.W.; Quinn S.M.; Beinborn M.

CCK-A receptor deficient mice develop gallstones and lack CCK mediated inhibition of food intake
pp. 97-97(1)
Authors: Kopin A.S.; Nguyen M.; Chiu M.; Beinborn M.; Schmitz F.; Wang D.; Carey M.; Kanarek R.; Mathes W.F.; Langhans N.; Ardman B.

Role of corticotropin-releasing factor in locus coeruleus activation induced by nociceptive colorectal distention in anesthetized rats
pp. 97-97(1)
Authors: Kosoyan H.; Tache Y.

Impaired gastrin, pancreatic polypeptide and vasoactive intestinal polypeptide secretion in noninsulin dependent diabetics with vagal neuropathy
pp. 98-98(1)
Authors: Kostic N.; Zamaklar M.; Bozanic M.

Presence of PACAP in the retinohypothalamic pathway
pp. 98-98(1)
Authors: Koves K.; Kausz M.; Fogel K.; Arimura A.

Water-avoidance stress-induced c-fos expression in cholecystokinergic and enkephalinergic neurons of the rat hypothalamus as revealed by the combination of immunocytochemistry with in situ hybridization.
pp. 99-99(1)
Authors: Kresse A.; Martinez V.; Tache Y.

Carbamylcholine induces expression of vasoactive intestinal polypeptide (VIP) in human neuroblastoma cell lines
pp. 99-99(1)
Authors: Kristensen B.; Georg B.; Fahrenkrug J.

Molecular cloning and cell specific localization of guanylyl cyclase-C (GC-C) and guanylyl cyclase activating peptides (GCAPs) in the kidney
pp. 100-100(1)
Authors: Kruhoffer M.; Kampf U.; Meyer M.; Cetin Y.; Forssmann W.G.

Peptide ligands of particulate guanylate cyclase-C: luminocrine modulators of electrolyte transport in human intestine.
pp. 100-100(1)
Authors: Kuhn M.; Hess R.; Martin S.; Fuchs M.; Adermann K.; Forssmann W.G.

Role of serotonine in regulation of metabolic activity of the lungs during obstructive jaundice.
pp. 101-101(1)
Authors: Kulyk O.M.; Mysoskovets O.H.; Zayachkivska O.S.; Antoniv O.I.; Makeyeva Y.I.

Adenosine modulates PACAP-evoked chloride secretion in guinea-pig distal colon
pp. 101-101(1)
Authors: Kuwahara A.; Kadowaki M.

Vagus nerve modulates secretin binding sites in rat forestomach.
pp. 102-102(1)
Authors: H. Y.K.; T. M.C.; K. Y.L.; W. Y.C.

Vagally-stimulated pancreatic secretion is mediated by CCK, VIP, PACAP and insulin in rats.
pp. 102-102(1)
Authors: H. Y.K.; K. Y.L.; T. M.C.; Coy D.; W. Y.C.

The use of 3-D reconstructions to examine the spatial localization of substance P receptors (NK-1), substance P and endopeptidase 24.11 immunoreactivity with reference to efferent gastric neurons in the dorsal motor nucleus of the vagus.
pp. 103-103(1)
Authors: Ladic L.; Buchan A.M.J.

The distribution of PACAP immunoreactive magnocellular hypophysiotropic neurons in the rat hypothalamus
pp. 103-103(1)
Authors: Lakatos A.; Arimura A.; Koves K.

Endothelin 3 expression by vagal neural crest cells
pp. 104-104(1)
Authors: Lancaster M.; Blackmore C.; Goldsmith J.; Edgar D.; Vaillant C.

Autocrine VIP regulation in the endothelium of cerebral vasculature in newborn piglets
pp. 104-104(1)
Authors: Lange D.; Funa K.; Wollina U.

Effects of peptides of the secretin superfamily in human pituitary adenomas
pp. 105-105(1)
Authors: Lania A.; Ballare E.; Ferraris A.; Losa M.; Persani L.; Faglia G.; Spada A.

Cloning of the human GLP-1 receptor gene and partial characterization of the promotor
pp. 105-105(1)
Authors: Lankat-Buttgereit B.; Rossel N.; Goke B.

A simple method for prediction of response to sandostatin treatment in patients with neuroendocrine tumours
pp. 106-106(1)
Authors: Larkin C.J.; Ong Y.L.; Shi W.; Buchanan K.D.

Demonstration of a glucagon-like peptide-1 synthesising neuronal circuit in the brain: Implications on feeding and drinking behaviour.
pp. 106-106(1)
Authors: Larsen P.J.; Tang-Christensen M.; Holst J.J.; Orskov C.

Secretoneurin during phylogeny and ontogeny
pp. 107-107(1)
Authors: Leitner B.; Hoflehner J.; Fischer-Colbrie R.; Winkler H.

Somatostatin, insulin and glucagon immunoreactivity in the human thymus
pp. 107-107(1)
Authors: Leposavic G.; Todorovic V.; Nikolic I.

Effect of M₃ muscarinic antagonist (4-DAMP) administration on non-stimulated and cholecystokinin-8-stimulated secretion of pancreatic juice and duodenal motility in conscious calves
pp. 108-108(1)
Authors: Lesniewska V.; Ceregrzyn M.; Pierzynowski S.; Zabielski R.

Secretin inhibits acid secretion via vagal capsaicin-sensitive afferent pathway in rats.
pp. 108-108(1)
Authors: P L.; T M.C.; W Y.C.

Mechanism of inhibition by PACAP of acid secretion in isolated perfused rat stomach.
pp. 109-109(1)
Authors: P. L.; T-M C.; D C.; W. Y.C.

Paracrine action of secretin on inhibition of gastric acid secretion in the rat.
pp. 109-109(1)
Authors: P L.; Y S.; T M.C.; W Y.C.

CCK-releasing peptide mediates oleic acid stimulated-secretion of CCK: involvement of intestinal submucosal cholinergic neurons.
pp. 110-110(1)
Authors: Y. L.; Hoa Y.; C. O.

Evidence that diazepam binding protein is involved in mediating feedback regulation of pancreatic secretion and postprandial release of CCK.
pp. 110-110(1)
Authors: Y. L.; Y H.; C. O.

Innervation of the pyloric sphincter of rat.
pp. 111-111(1)
Authors: Lindestrom L.-M.; Hannibal J.; Sundler F.; Ekblad E.

Release of Pancreastatin and Histamine from Isolated Rat Stomach ECL cells
pp. 111-111(1)
Authors: Lindstrom E.; Boketoft A.; Bjorkquist M.; Duan C.; Chun-Mei Z.; Kimura K.; Hakanson R.

A study on epidermal growth factor receptors in human colorectal cancer.
pp. 112-112(1)
Authors: G M.L.; R L.J.

Amylin inhibits glycogen synthase activity and glucose uptake in L6 rat myoblasts at physiological concentrations.
pp. 112-112(1)
Authors: J L.; Adrian T.

A new protein from pituitary gland regulating intestinal mucosal permeability
pp. 113-113(1)
Authors: Lonnroth I.; Johansson E.; Lange S.; Jennische E.; Jonsson I.; Lonnroth C.

Association of the SH2 domain-containing protein tyrosine phosphatase PTP1C with the sst2 somatostatin receptor and its activation by somatostatin
pp. 113-113(1)
Authors: Lopez F.; Esteve J.P.; Buscail L.; Delesque N.; Saint-Laurent N.; Theveniau M.; Reisine T.; Vaysse N.; Susini C.

The Human Galanin-1 Receptor: GI Tract Distribution, Genomic Organization, and Chromosomal Localization
pp. 114-114(1)
Authors: Lorimer D.; Benya R.

The effect of motilin infusion on gallbladder volume and antral motility in man
pp. 114-114(1)
Authors: Luiking Y.C.; Peeters T.L.; Portincasa P.; van de Meeberg P.C.; Nieuwenhuijs V.B.; van Berge Henegouwen G.P.; Akkermans L.M.A.

Endothelin and NPY receptors in human parathyroid gland
pp. 115-115(1)
Authors: Luts L.; Bergenfelz A.; Cantera L.; Edvinsson L.; Sundler F.

Signalling by the wild type rat VIP₂ receptor and carboxyl tail truncated forms transiently expressed in COS 7 cells
pp. 115-115(1)
Authors: Lutz E.M.; MacKenzie C.J.; Mitchell R.; Bennie J.; Carroll S.; Harmar A.J.

Medium-chain triglycerides induce peptide YY release in humans
pp. 116-116(1)
Authors: Maas M.I.M.; Hopman W.P.M.; Katan M.B.; Jansen J.B.M.J.

Study of the promoter of the rat glucagon gene: 1/ Tissue specific polymorphism of the 5' end of glucagon receptor mRNA
pp. 116-116(1)
Authors: Maget B.; Tastenoy M.; Svoboda M.

Study of the promoter of the rat glucagon receptor gene: 2/Cloning of the promoter domain.
pp. 117-117(1)
Authors: Maget B.; Tastenoy M.; Svoboda M.

Importance of Gastrin and other Growth-Factors in Growth Regulation of Rat Gastric Enterochromaffinlike (ECL) Cells in Primary Culture.
pp. 117-117(1)
Authors: Mahr S.; Kolb H.; Schepp W.; Classen M.; Prinz C.

Aging enhances gastric mucosal sensitivity to EGF and TGF-
pp. 118-118(1)
Authors: Majumdar A.P.N.; Fligiel S.E.G.; Tureaud J.

Differential responsiveness of proximal and distal colonic mucosa of rats to the trophic action of gastrin
pp. 118-118(1)
Authors: Majumdar A.P.N.; Malecka-Panas E.; Fligiel S.E.G.

NPY mediates sympathetic vasoconstriction: evidence using SR 120107A in reserpinized pigs in vivo.
pp. 119-119(1)
Authors: Malmstrom R.E.; Modin A.; Lundberg J.M.

CGRP-immunoreactivity in OLETF rat pancreas
pp. 119-119(1)
Authors: Manaka H.; Manaka Y.; Kato T.; Yamatani K.; Tominaga M.; Yamaguchi K.; Sasaki H.

Regulation of the bile secretion in rats by enkephalines
pp. 120-120(1)
Authors: Masyuk A.; Masyuk T.

Isolation and bioactivity of component peptides in the venom of the bumblebee (Megabombus pennsylvanicus)
pp. 120-120(1)
Authors: McClelland A.K.; Cross M.; Halton D.W.; Shaw C.

Cellular and subcellular localization of G-protein receptor kinases, arrestins and G-proteins: implications for receptor regulation
pp. 121-121(1)
Authors: McConalogue K.; Grady E.F.; Bunnett N.W.

[Mpr¹⁴]-rADM(14-50), a novel analog of adrenomedullin, possesses potent vasodilator activity in the hindlimb vascular bed of the cat
pp. 121-121(1)
Authors: McNamara D.B.; Champion H.C.; Murphy W.A.; Coy D.H.; Kadowitz P.J.

Co-localisation of three chromogranin A-derived peptides: vasostatin II; pancreastatin and WE-14 with follicle stimulating hormone and luteineizing hormone in the rat anterior pituitary
pp. 122-122(1)
Authors: McVicar C.M.; Cunningham R.T.; Curry W.J.; Johnston C.F.; Buchanan K.D.

Hypo - and hyperinsulinemia as regulatory factors of somatostatin secretion in the hypothalamus median eminence
pp. 122-122(1)
Authors: Medvedev D.I.; Babichenko I.I.

Peptidases responsible for the inactivation of neuropeptide Y
pp. 123-123(1)
Authors: Mentlein R.; Ludwig R.; Roos T.

Gastric relaxation induced by VIP and long-duration vagal stimulation is not changed after no-synthase inhibition in anesthetized dogs
pp. 123-123(1)
Authors: Meulemans A.L.; Schuurkes J.J.

GCAP I as a paracrine peptide in pancreatic islets modulates insulin release from B-cells
pp. 124-124(1)
Authors: Meyer M.; Kruhoffer M.; Laffranchi R.; Reinecke M.; Forssmann W.

Gastrointestinal Physiology of Somatostatin Receptor Subtypes
pp. 124-124(1)
Authors: Meyerhof W.; Roosterman D.; Schafer J.; Baumeister H.; Roth A.; Richter D.

Putative roles of TGF- in normal and neoplastic murine colon
pp. 125-125(1)
Authors: Mikhailowski R.; Shpitz B.; Schwartz B.; Segal C.; Lamprecht S.A.

Influence of extrinsic denervation and surgical reinnervation of the pancreas on its functional reaction to humoral agents
pp. 125-125(1)
Authors: Mikhalsky D.V.; Coulic V.P.

Increased NPYergic neurotransmission reduces hippocampal-induced seizures: An autoregulatory mechanism
pp. 126-126(1)
Authors: Mikkelsen J.D.; Woldbye D.P.D.; Madsen T.M.; Larsen P.J.; Bolwig T.G.

Different bombesin receptor subtypes mediate contractile responses in the cat esophagus and fundus
pp. 126-126(1)
Authors: Milusheva E.; Mizhorkova Z.; Kortezova N.; Papasova M.; Coy D.H.; Vizi E.S.; Varga G.

The augmentation of pituitary adenylate cyclase activating polypeptide (PACAP) in the streptozotocin-induced diabetic rats
pp. 127-127(1)
Authors: Miyata A.; Tamakawa H.; Honzawa M.; Arimura A.; Matsuo H.; Kangawa K.

Time-dependent Changes of Vasoactive Substances in the Rat Amygdaloid Complex after Transient Cerebral Ischemia
pp. 127-127(1)
Authors: Mizushima H.; Sasaki K.; Arai Y.; Honma H.; Dohi K.; Matsumoto K.; Shioda S.; Nakai Y.

Central effects of endotelin in the ultra low doses
pp. 128-128(1)
Authors: Moghimi A.; Chepurnova N.E.; Smirnova M.P.; Chepurnov S.A.

Increase of AT1 receptors and diminution of c-Fos following repetitive central injections of angiotensin II
pp. 128-128(1)
Authors: Mollenhoff E.; Herdegen T.; Lebrun C.J.; Blume A.; Unger T.

Plasticity of pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP type-1 receptor expression in regenerating superior cervical ganglia
pp. 129-129(1)
Authors: Moller K.; Reimer M.; Hannibal J.; Fahrenkrug J.; Kanje M.; Sundler F.

The density of neuropeptide Y (NPY)-containing nerve fibres in the pineal gland of the European hamster (Cricetus cricetus) exhibits an annual variation.
pp. 129-129(1)
Authors: Moller M.; Masson-Pevet M.; Pevet P.

Effects of rabbit motilin on feeding, learning and anxiety behaviors in mice
pp. 130-130(1)
Authors: Momose K.; Inui A.; Seki W.; Uemoto M.; Nakajima M.; Ueno N.; Kasuga M.

Intraduodenal infusion of lipids induces c-fos expression in the locus coeruleus, area postrema, nucleus os the solitary tract and paraventricular nucleus of the hypothalamus via CCK-A receptors and capsaicin-sensitive vagal pathways
pp. 130-130(1)
Authors: Monnikes H.; Lauer G.; Arnold R.

Intraoperative gamma detection of ¹²⁵I-lanreotide in women with primary breast cancer.
pp. 131-131(1)
Authors: Montani M.; Levine E.; Watson J.; Wray D.; Alperin-Lea R.; Espenan G.; McKnight C.; O'Dorisio M.; O'Dorisio T.; Woltering E.A.

Elimination of GLP-1 action in vivo by a new antagonist of GLP-1 receptor, exendin-4 (3-39).
pp. 131-131(1)
Authors: Montrose-Rafizadeh C.; J. E.; Y. W.; Grieg N.; Egan J.M.

The cutaneous vasodilator maxadilan is a specific PACAP type I receptor agonist.
pp. 132-132(1)
Authors: Moro O.; Lerner E.A.

Transforming growth factor-₁ as an apoptotic agent in L1210 leukemic cells.
pp. 132-132(1)
Authors: Motyl T.; Grzelkowska K.; Kasterka M.; Skierski J.; Ostrowski J.

Determination of sorting related structures in human progastrin
pp. 133-133(1)
Authors: Munksgaard C.; Rehfeld J.F.; Bundgaard J.R.

Galanin affects REM sleep and nonREM sleep without changing nocturnal hormonal secretion in man
pp. 133-133(1)
Authors: Murck H.; Maier P.; Frieboes R.M.; Schier T.; Holsboer F.; Steiger A.

Weaning human pancreatic cancer cells from dependence on serum increases autocrine growth factor secretion and alters receptor density.
pp. 134-134(1)
Authors: Murphy L.; Abdel-Wahab Y.; Hollingsworth A.; Permert J.; Larsson J.; Adrian T.

Inhibition of human pancreatic tumor cell proliferation by lamprey gonadotrophin releasing hormone.
pp. 134-134(1)
Authors: Murphy L.; Lovas S.; Murphy R.; Adrian T.

Characterization of PACAP receptors using PACAP(6-27) in the mesenteric vascular bed of the cat.
pp. 135-135(1)
Authors: Murphy W.A.; Champion H.C.; Coy D.H.; McNamara D.B.; Kadowitz P.J.

Studies on binding on tumor cells of Xenin
pp. 135-135(1)
Authors: Muller A.; Schleppegrell T.; Alves F.; Nustede R.; Becker H.

Dexamethasone induces NPY expression in insulin-producing RINm5F cells: Evidence for constitutive release of NPY and impaired insulin secretion.
pp. 136-136(1)
Authors: Myrsen U.; Ahren B.; Sundler F.

Expression of NPY, PYY, PP and their coexistence with other islet hormones during development of the rat pancreas.
pp. 136-136(1)
Authors: Myrsen U.; Ekblad E.; Sundler F.

Light and electron microscopical studies of PACAP (pituitary adenylate cyclase activating polypeptide) immunoreactive neurons in the myenteric plexus of rat intestine.
pp. 137-137(1)
Authors: Nagahama M.; Tsuzuki T.; Kuwahara A.; Mochizuki T.

Neuropeptide Y produces anxiety via Y2-type receptors
pp. 137-137(1)
Authors: Nakajima M.; Inui A.; Ueno N.; Teranishi A.; Okita M.; Baba S.; Kasuga M.

Guanylin and uroguanylin: novel peptide regulators for fluid and electrolyte homeostasis.
pp. 138-138(1)
Authors: Nakazato M.; Yamaguchi H.; Miyazato M.; Date Y.; Matsukura S.; Kangawa K.; Matsuo H.

Structure-activity relationship of PACAP/VIP related peptides in the gastrointestinal tract
pp. 138-138(1)
Authors: Naruse S.; Wei M.; Nakamura T.; Ando E.; Nokihara K.; Wray V.; Ozaki T.; Hayakawa K.; Hayakawa T.

Cellular mechanisms of CCK release induced by peptones and peptidomimetic antibiotics in the STC-1 cell line.
pp. 139-139(1)
Authors: Nemoz-Gaillard E.; Bernard C.; Abello J.; Cuber J.C.

Site-directed mutagenesis provides evidence for difference in the structure-function relationship of human vasoactive intestinal peptide (VIP) 1 and 2 receptor subtypes
pp. 139-139(1)
Authors: Nicole P.; Du K.; Couvineau A.; Laburthe M.

Developmental Expression of the Pituitary adenylate cyclase activating polypeptide (PACAP) in rat autonomic ganglia and spinal cord.
pp. 140-140(1)
Authors: Nielsen H.S.; Hannibal J.; Fahrenkrug J.

Distinct biological activities of endogenous gastrin and cholecystekinin (CCK) in bullfrog.
pp. 140-140(1)
Authors: Nielsen K.G.; Bomgren P.; Johnsen A.H.

Long-term treatment with octreotide and octreoscan scintigraphy in patients with metastatic carcinoids
pp. 141-141(1)
Authors: Nikou G.C.; Arnaouti T.; Samolada O.; Kikilas A.; Kitsou E.; Kyriaki D.; Alevizou V.

Possible Role of Gamma-aminobutyric Acid on Galanin Release from Rat Hypothalamus
pp. 141-141(1)
Authors: Nishiki M.; Murakami Y.; Koshimura K.; Sohmiya M.; Kato Y.

Binding Studies and cGMP Production of Guanylin and its Disulfide Isomer using Rat Intestine
pp. 142-142(1)
Authors: Nokihara K.; Ando E.; Naruse S.; Ieda H.; Wray V.; Hayakawa T.

Expression of chromogranin A-derived peptides pancreastatin and WE₁₄ in rat stomach ECL cells
pp. 142-142(1)
Authors: Norlen P.; Curry W.; D C.; C-M Z.; Johnston C.; Hakanson R.

Studies on the mode of action of Xenin related peptides on the exocrine pancreas invivo in dogs
pp. 143-143(1)
Authors: Nustede R.; Schmidt W.E.; Sikovec N.; Messow M.; Horstmann O.; Becker H.

Postprandial CCK- and Gastrin-response and inhibition of Gallbladder Contracting by Omeprazole or Ranitidine Treatment
pp. 143-143(1)
Authors: Nustede R.; Wustner M.; Becker H.; Creutzfeldt W.

Cholecystokinin-A and Cholecystokinin-B/Gastrin Receptor mRNA Expression in the Gastrointestinal Tract and Pancreas of the Rat and Man. A PCR study.
pp. 144-144(1)
Authors: Nylander A.-G.; Monstein H.-J.; Salehi A.; Chen D.; Lundquist I.; Hakanson R.

Increased Expression of mRNA for the CCK-A Receptor in Pancreas and the CCK-B Receptor in Oxyntic Mucosa after Porta-caval Shunting in Rats.
pp. 144-144(1)
Authors: Nylander A.-G.; von Friesen C.P.; Monstein H.-J.; Yamada H.; Chen D.; Boketoft A.; Hakanson R.

Development of a novel somatostatin analogue with high affinity for human sst1 and sst2
pp. 145-145(1)
Authors: O'Dorisio M.; Chen F.; Albers A.; Woltering E.; O'Dorisio T.; Murphy W.; Coy D.

Development of biologically active N-terminally substituted, multi-tyrosinated somatostatin analogs.
pp. 145-145(1)
Authors: O'Dorisio T.; O'Dorisio M.; Chen F.; Murphy W.; Coy D.; Woltering E.

Immunoelectron microscopic demonstration of luminal release of serotonin from rat EC cells induced by high intraluminal pressure
pp. 146-146(1)
Authors: Okumiya K.; Kuwahara A.; Fujimiya M.

CCK inhibition of the stomach of the rainbow trout, Oncorhynchus mykiss, is not mediated by nitric oxide
pp. 146-146(1)
Authors: Olsson C.; Aldman G.; Holmgren S.

Detection of c-erbB-2 protein and mRNA overexpression by immunohistochemistry and in situ hybridization in human breast carcinoma
pp. 147-147(1)
Authors: Ozturk M.; Bolkent S.; Kaner G.; Yilmazer S.

Cholecystokinin in plasma and pleural fluid of patients with lung cancer
pp. 147-147(1)
Authors: Paloheimo L.; Liippo K.; Rehfeld J.

Neuropeptide-mediated modulation of sensory processing in the lamprey spinal cord
pp. 148-148(1)
Authors: Parker D.; Ullstrom M.; Grillner S.

Inhibition of dipeptidyl peptidase IV (DP IV) in rat results in improved glucose tolerance
pp. 148-148(1)
Authors: Pauly R.P.; Demuth H.-U.; Rosche F.; Schmidt J.; White H.A.; McIntosh C.H.S.; Pederson R.A.

Gip and insulin values during OGTT in patients with PCOS
pp. 149-149(1)
Authors: Paunovic-Pavic D.; Micic D.; Kendereski A.; Sumarac-Dumanovic M.; Zoric S.; Macut D.; Colic M.; Manojlovic D.

Distinct regulation of translation by phosphatidyl-inositol 3-OH kinase and p70/85^s6k
pp. 149-149(1)
Authors: Pedersen S.; Nielsen J.; Christiansen J.; Nielsen F.C.

Correlations between gastrin releasing peptide (GRP), gastrin (G) and helicobacter pylori (HP).
pp. 150-150(1)
Authors: Peikin S.; Spiegel T.; Elfant A.; Saniour P.; O'Dorisio T.

Evolution of gastrin during long term lansoprazole treatment.
pp. 150-150(1)
Authors: Penson J.; Puttemans M.; Fourie E.

Effect of prostaglandin E₂ (PGE₂) on lipides peroxide oxidation processes (LPO) and on antioxidant system (AOS) of mucous coat of the stomach in rats of advanced age.
pp. 151-151(1)
Authors: Petryshyn Y.S.; Lukovych I.M.; Hatalyak B.V.; Shalko I.V.

Postprandial changes in renal function are mediated by elevated serum gastrin acting at cholecystokinin type B receptors (CCKBR) in the kidney
pp. 151-151(1)
Authors: Pisegna J.R.; Tarasova N.I.; Kopp J.A.; Jose P.; Farnsworth D.W.; Michejda C.J.; Wank S.A.

Keratinocyte growth factor (KGF) & gastrointestinal epithelial proliferation, crypt branching and gut hormone release.
pp. 152-152(1)
Authors: Playford R.; Mandir N.; Meeran K.; Ghatei M.; Bloom S.; Wright N.; Goodlad R.

The central mechanisms of aggression in rats: participation of cholecystokinin-octapeptide and beta-endorphin.
pp. 152-152(1)
Authors: Pletnicov M.V.; Sherstnev V.V.

The carboxy-terminus of the cholecystokinin type B receptor (CCKBR), unlike that of the type A receptor (CCKAR), is important for ligand-induced inter-nalization.
pp. 153-153(1)
Authors: Pohl M.; Poirot S.S.; Pisegna J.R.; Tarasova N.I.; Wank S.A.

Somatostatin cells in dog gastric mucosa have gastrin/CCK-B receptors.
pp. 153-153(1)
Authors: Poorkhalkali N.; Wong H.; Walsh J.; Helander H.

Immunohistochemical localization of neurokinin receptors in the guinea-pig gastrointestinal tract
pp. 154-154(1)
Authors: Portbury A.L.; Southwell B.R.; Young H.M.; Furness J.B.

Co-localization of chromogranins and neuroendocrine hormones in the human gastrointestinal mucosa
pp. 154-154(1)
Authors: Portela-Gomes G.M.; Grimelius L.; Stridsberg M.; Johansson H.

Isolation and sequencing of a novel family of leucine-rich peptides (LRPs) from the skin of the European common frog, Rana temporaria
pp. 155-155(1)
Authors: Powell L.A.; Cross M.; Halton D.W.; Robson J.; Shaw C.

Effects of Proinflammatory Interleukins on Isolated Rat Enterochromaffinlike Cells.
pp. 155-155(1)
Authors: Prinz C.; Neumayer N.; Classen M.; Schepp W.

Differential distribution of trefoil polypeptides in the hypothalamo-hypophyseal system and immune system
pp. 156-156(1)
Authors: Probst J.C.; Landgraf R.; Stalla G.K.; Zetzsche T.

Orally administered lectins induce release of CCK from the duodenum and the growth of the pancreas which is blocked by CCK-A receptor antagonists
pp. 156-156(1)
Authors: Pusztai A.; Grant G.; Baintner K.; Bardocz S.; Herzig K.H.; Folsch U.R.; Nustede R.

A role for melanin-concentrating hormone in the central regulation of feeding behaviour
pp. 157-157(1)
Authors: Qu D.; Ludwig D.S.; Gammeltoft S.; Piper M.; Pelleymounter M.A.; Cullen M.J.; Mathes W.F.; Przypek J.; Kanarek R.; Maratos-Flier E.

Plasma concentration of motilin is changed by antrectomy and selective gastric vagotomy but not cholecystokinin and gallbladder motility
pp. 157-157(1)
Authors: Qvist N.; Andersen P.; Oster-Jorgensen E.; Rasmussen L.; Pedersen S.A.; Holst J.J.; Rehfeld J.F.

Regulation of postprandial GLP-1 secretion by non-esterified fatty acids
pp. 158-158(1)
Authors: Ranganath L.; Morgan L.; Norris F.; Hampton S.; Wright J.; Marks V.

The relationship between gut hormone secretion and gastric emptying in different phases of the migrating motor complex
pp. 158-158(1)
Authors: Rasmussen L.; Oster-Jorgensen E.; Qvist N.; Holst J.J.; Rehfeld J.F.; Hovendal C.P.; Pedersen S.A.

A double-blind placebo-controlled study on the effects of omeprazole on postprandial levels of gut hormones and gastric emptying rate
pp. 159-159(1)
Authors: Rasmussen L.; Qvist N.; Oster-Jorgensen E.; Rehfeld J.F.; Holst J.J.; Pedersen S.A.

Restricted access to food stimulated endogenous CCK release and attenuated the pancreatic function in rats.
pp. 159-159(1)
Authors: Rayford P.L.; Chowdhury P.

Breast cancer initiates human angiogenesis but does not accelerate vessel growth rate.
pp. 160-160(1)
Authors: Redmann J.G.; Watson J.C.; Alperin-Lea R.C.; Woltering E.A.

Kinin receptors in the cardiovascular system
pp. 160-160(1)
Author: Regoli D.

Isolation and structure of tissue specific mitosis inhibitors
pp. 161-161(1)
Authors: Reichelt K.L.; Elgjo K.; Gembitsky D.; Paulsen J.-E.

The Mechanism of GABA-induced Gastroprotction Against Ethanol Injury in the Rat.
pp. 161-161(1)
Authors: Ren J.; Anderson M.; Xia Y.; Xiao S.; Harty R.

The storage form of cardiodilatin/atrial natriuretic peptide in porcine heart
pp. 162-162(1)
Authors: Richter R.; Schulz-Knappe P.; Raida M.; Forssmann W.-G.

Different isoforms of enterostatin and the lipase/colipase ratio in various species
pp. 162-162(1)
Authors: Rippe C.; Erlanson-Albertsson C.

Naturally occurring enhancing and artificial antagonistic zinc-sites in tachykinin NK-2 and NK-3 receptors and ligands.
pp. 163-163(1)
Authors: Rosenkilde M.M.; Lucibello M.; Hansen B.H.; Blomqvist A.; Elling C.E.; Hjorth S.A.; Weber P.J.A.; Beck-Sickinger A.; Schwartz T.W.

Prediction of protein tyrosine sulfation sites
pp. 163-163(1)
Authors: Rosenquist G.L.; Chan S.S.; Phan T.P.; Nicholas H.B.

Adrenomedullin, calcitonin gene related peptide and amylin are powerful inhibitors of gastric acid secretion in conscious rats.
pp. 164-164(1)
Authors: Rossowski W.J.; N-Y. J.; B.-L. C.; Coy D.H.

Post-translational processing of human cholecystokinin expressed in yeast: cleavage AT Lys⁸¹ by an unidentified yeast endoprotease
pp. 164-164(1)
Authors: Rourke I.J.; Din N.; Petersen J.G.L.; Johnsen A.H.; Rehfeld J.F.

Does GLP-1 have an insulin-like effect during euglycemia in humans?
pp. 165-165(1)
Authors: Ryan A.S.; Egan J.M.; Habener J.F.; Elahi D.

Peptide leucine arginine (pLR): a novel histamine-releasing octadecapeptide from the skin of the Northern leopard frog, Rana pipiens
pp. 165-165(1)
Authors: Salmon A.; Cross M.; Johnston R.N.; Halton D.W.; Thim L.; Shaw C.

Generation of a CCK loss of function mutation in the mouse by homologous recombination in ES cells.
pp. 166-166(1)
Authors: Samuelson L.C.; Gillespie P.J.; Lay J.M.; Swanberg L.J.; Seasholtz A.F.; Saunders T.L.

Carbachol stimulates acid secretion mainly by a direct effect on the parietal cell.
pp. 166-166(1)
Authors: Sandvik A.K.; Marvik R.; Dimaline R.; Waldum H.L.

Gastrin release in the fetal lamb in response to luminal infusion of amniotic fluid, milk or GRP
pp. 167-167(1)
Authors: Sangild P.T.; Hilsted L.; Bjornskov-Bartholdy L.; Holst J.J.; Trahair J.F.

Gastrin secretion in response to amniotic fluid or milk in the fetal pig GI tract
pp. 167-167(1)
Authors: Sangild P.T.; Hilsted L.; Silver M.; Fowden A.L.

Unresponsiveness of the prenatal pig stomach to GRP and gastrin in utero
pp. 168-168(1)
Authors: Sangild P.T.; Schmidt M.H.; Pierzynowski S.R.; Greve T.

cDNA cloning and sequencing of a novel human early response gene and characterization of its expression in pancreatic carcinoma cells.
pp. 168-168(1)
Authors: Schafer H.; Trauzold A.; Lettau P.; Neumann P.; Kalthoff H.; Folsch U.R.; Schmidt W.E.

Nitric oxide (NO) synthesis is a critical step for wound collagen accumulation.
pp. 169-169(1)
Authors: Schaffer M.; Gross S.; Wasserkrug H.; Barbul A.

Acute protein-calorie malnutrition (PCM) impairs wound healing: role of wound nitric oxide (NO) synthesis.
pp. 169-169(1)
Authors: Schaffer M.; Tantry U.; Ahrendt G.; Wasserkrug H.; Barbul A.

Effects of subcutaneous GLP-1 on postprandial glucose homoiostasis and gastric emptying in NIDDM.
pp. 170-170(1)
Authors: Schirra J.; Leicht P.; Hildebrand P.; Beglinger C.; Arnold R.; Goke B.; Katschinski M.

Effects of GLP-1 on human antro-pyloro-duodenal motility.
pp. 170-170(1)
Authors: Schirra J.; Wank U.; Houck P.; Arnold R.; Goke B.; Katschinski M.

Fundic somatostatin-mediated inhibition of gastrin- stimulated acid secretion is defective in H. pylori gastritis.
pp. 171-171(1)
Authors: Schmidt W.E.; Bojko J.B.; Burlage M.; Schafer H.; Folsch U.R.; Nustede R.; Stolte H.

Isolation of regulatory peptides from human blood
pp. 171-171(1)
Authors: Schulz-Knappe P.; Raida M.; Hesz R.; Kleemeier B.; Richter R.; Schrader M.; Standker L.; Forssmann W.-G.

The effect of pancreatic polypeptide on hepatocyte insulin receptor concentration.
pp. 172-172(1)
Authors: Seymour N.; Volpert A.; Frattini J.; Andersen D.

Helminth FMRFamide-related peptides (FaRPs) - structures and actions
pp. 172-172(1)
Authors: Shaw C.; Maule A.G.; Marks N.J.; Johnston R.N.; Geary T.G.; Thompson D.P.; Thim L.; Halton D.W.

Immunocytochemistry Localization of Protein kinase C (PKC) and Somatostatin in Neuroendocrine Tumours
pp. 173-173(1)
Authors: Shi W.; Johnston C.; Buchanan K.

Expression of cholecystokinin in rat pancreas.
pp. 173-173(1)
Authors: Shimizu K.; Shiratori K.; Watanabe S.; Kato Y.; Kobayashi M.; T-M C.; W. Y.C.

Cellular Localization and Functional Significance of PACAP and Its Receptors in Rat Hypothalamus
pp. 174-174(1)
Authors: Shioda S.; Yada T.; Nakajo S.; Nakaya K.; Nakai Y.; Arimura A.

The physiological role of gastrin, CCK, and acetylcholine in gastric acid secretion in the gastric phase in rats.
pp. 174-174(1)
Authors: Shiratori K.; Shimizu K.; Watanabe S.

Molecular Cloning of a cDNA Encoding Mouse Phospholipase C-3
pp. 175-175(1)
Authors: Wang S.; Yinghua Z.; Skogseid B.; Oberg K.; Gobl A.

Bases of mediators and hormones interaction in the mucous membrane of stomach.
pp. 175-175(1)
Authors: Sklyarov A.; Kosyj Y.; Plazko M.; Sklyarova V.

Modulation of bombesin-induced, PKC mediated contraction by Gi protein during smooth muscle contraction in rabbit colon.
pp. 176-176(1)
Authors: Sladick J.; Kothary P.; Bitar K.N.

GRP induced proliferation of Swiss 3T3 cells is specifically blocked by bafilomycin.
pp. 176-176(1)
Authors: Slice L.W.; Walsh J.H.

Characterisation of adrenomedullin receptors and the presence of adrenomedullin mRNA and immunoreactivity in the rat spinal cord.
pp. 177-177(1)
Authors: Smith D.M.; Ghatei M.A.; Owji A.A.; Gardiner J.V.; Upton P.D.; Bloom S.R.

Primary structure of a novel mast cell degranulating peptide from the skin of the African frog, Hylambates maculatus, exhibiting an unusual post-translational modification
pp. 177-177(1)
Authors: Smyth A.F.; Cross M.; Johnsen A.; Halton D.W.; Shaw C.

Role of Gastrin and Acetylcholine Regulation of Histidine Decarboxylase in Gastric ECL cells during Refeeding in Rat
pp. 178-178(1)
Authors: Min S.; Wong H.; Ohning G.V.; Wu V.; Hong Y.; Tache Y.; Walsh J.H.

Inhibition by secretin of histamine release from ECL cell is mediated by somatostatin in rat.
pp. 178-178(1)
Authors: Y S.; P L.; T-M C.; K Y.L.; W Y.C.

The proliferation of bladder cancer cells is inhibited by antisense oligonucleotides directed against transforming growth factor .
pp. 179-179(1)
Authors: Sorensen B.S.; Nexo E.

Enterostatin signalling by inositol phosphate in human neuroblastoma SK-N-MC cells
pp. 179-179(1)
Authors: Sorhede M.; Nilsson C.; Erlanson-Albertsson C.

Agonist induced endocytosis of NK1 receptors on enteric neurons demonstrated by confocal microscopy
pp. 180-180(1)
Authors: Southwell B.R.; Woodman H.L.; Royal S.J.; Murphy R.; Furness J.B.

Purification and characterization of a luminal cholecystokinin-releasing factor (LCRF) from rat intestinal secretion.
pp. 180-180(1)
Authors: Spannagel A.W.; Green G.M.; Guan D.; Liddle R.A.; Faull K.; Reeve J.R.

Identification and mechanism of action of the calcium-sensing receptor on human antral gastrin cells in short term culture.
pp. 181-181(1)
Authors: Squires P.; Ray J.; Meloche R.M.; Buchan A.M.J.

Detection of peptide hormones in neuroendocrine cells at the mRNA level: Comparison of RT-PCR in-situ hybridization and nonradioactive in-situ hybridization
pp. 181-181(1)
Authors: Steinhoff M.; Hesse H.; Goke B.; Slater E.P.

Glycine-extended gastrin exerts growth-promoting effects on colonic and pancreatic cells.
pp. 182-182(1)
Authors: Stepan V.; Sawada M.; Yamada T.; Dickinson C.

Evidence that somatostatin receptor 2A (SSTR2A) mediates multiple actions of somatostatin in the gastrointestinal tract.
pp. 182-182(1)
Authors: Sternini C.; H. W.; Reeve J.; Brecha N.; Walsh J.H.

Role of hepatocyte growth factor (HGF) and trefoil peptides in experimental gastric ulcer healing
pp. 183-183(1)
Authors: Stettler C.; Hirschi C.; Schmassmann A.; Poulsom R.; Tarasova N.; Matsumoto K.; Nakamura T.; Flogerzi B.; Halter F.

Effect of omeprazole treatment on plasma concentrations of the gastric peptides: xenin, gastrin, and somatostatin, and of pepsinogen.
pp. 183-183(1)
Authors: Stoschus B.; Ikonomou S.; Partoulas G.; Hamscher G.; Eberle C.; Sauerbruch T.; Feurle G.E.

The effects of Delta Sleep Inducing Peptide on electric-probe burying behavior in rats in accordance to their type of aversive behavior
pp. 184-184(1)
Author: Strekalova T.V.

The effect of bombesin on the growth of immortalized normal human gastric mucosal cells and its possible mechanism.
pp. 184-184(1)
Authors: Tao S.; Yuan-Fang C.; Yang K.

Do ECL cells in the rat oxyntic mucosa secrete a calciotropic hormone?
pp. 185-185(1)
Authors: Surve V.V.; Hakanson R.

Plasma -endorphin, ACTH and cortisol concentration in children with early onset epilepsy.
pp. 185-185(1)
Authors: Sztefko K.; Kacinski M.; Szafran Z.; Bando B.; Kroczka S.

The GEP neuroendocrine system in fishes: distribution and ontogeny
pp. 186-186(1)
Authors: Tagliafierro G.; Faraldi G.; Morescalchi A.

The probable arrangement of the transmembrane helices in the secretin receptor family
pp. 186-186(1)
Authors: Tams J.W.; Knudsen S.M.; Fahrenkrug J.

Expression of Receptors for Gut Peptides in Pancreata of BOP-treated and Control Hamsters
pp. 187-187(1)
Authors: Tang C.; Biemond I.; Appel M.J.; Visser C.J.T.; Woutersen R.A.; Lamers C.B.H.W.

Cholecystokinin Receptors in Human Pancreas and Gallbladder Muscle: A Comparative Study
pp. 187-187(1)
Authors: Tang C.; Biemond I.; Lamers C.B.H.W.

Expression of Receptors for Gut Peptides in Human Pancreatic Adenocarcinoma and Normal Pancreas
pp. 188-188(1)
Authors: Tang C.; Biemond I.; Offerhaus G.J.A.; Lamers C.B.H.W.

The inhibitory effect of Glucagon-Like-Peptide 1 (GLP-1) (7-36)amide on food and water intake in rats is abolished after neonatal treatment with Mono-Sodium Glutamate (MSG).
pp. 188-188(1)
Authors: Tang-Christensen M.; Sheikh S.; Larsen P.J.

Cholecystokinin secreting capacity of the intestinal mucosa in patients with coeliac disease.
pp. 189-189(1)
Authors: Thimister P.W.L.; Hopman W.P.M.; Rosenbusch G.; Jansen J.B.M.J.

Expression of transforming growth factor alpha and the epidermal growth factor receptor in human bladder tumors.
pp. 189-189(1)
Authors: Thogersen V.B.; Sorensen B.S.; Jorgensen P.E.; Nexo E.

Functional characterisation of neurokinin receptors mediating ion transport in porcine jejunum.
pp. 190-190(1)
Authors: Thorboll J.E.; Bindslev N.; Hansen M.B.; Schmidt P.; Skadhauge E.

Regulated Maturation of CCK/gastrin Prohormones Involves Tyrosine Sulfation and a Short C-terminal Acidic Motif.
pp. 190-190(1)
Authors: Thorup J.U.; Bundgaard J.R.; Rehfeld J.F.

Urinary excretion of epidermal growth factor (EGF) and tammhorsfall protein (THP) in rats with altered kidney function.
pp. 191-191(1)
Authors: Thulesen J.; Jorgensen P.E.; Torffvit O.; Nexo E.; Poulsen S.S.

Molecular mechanisms for the growth factor action of gastrin.
pp. 191-191(1)
Authors: Todisco A.; Takeuchi Y.; Yamada J.; Urumov A.; Stepan V.; Dickinson C.J.; Yamada T.

Neuropeptides in rat stomach after chronic alcohol ingestion - a immunohistochemical study
pp. 192-192(1)
Authors: Todorovic V.; Koko V.; Lackovic V.; Micev M.

The function of PACAP 1-38 as transmitter in the neural control of pancreatic secretion; activation of PACAP-receptors revealed by the antagonist PACAP 6-38.
pp. 192-192(1)
Authors: Tornoe K.; Hannibal J.; Holst J.J.

Systemic treatment with Insulinlike Growth factor-I (IGF-I) causes growth of the Prostate in the rat.
pp. 193-193(1)
Authors: Torring N.; Jensen L.V.; Flyvbjerg A.; Pedersen S.B.; Sorensen F.B.; Nexo E.

Gastrin Release after Stimulation by defined and intact dietary Proteins in a Polarized Organ Culture
pp. 193-193(1)
Authors: Triebener-Windrich C.; Flesch I.; Teichmann R.; Becker H.D.

Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP): effect of a GIP-specific receptor antagonist.
pp. 194-194(1)
Authors: Tseng C.-C.; Kieffer T.; Jarboe L.; Usdin T.; Wolfe M.

Molecular and cellular mechanisms governing glucose-dependent insulinotropic polypeptide receptor desensitization.
pp. 194-194(1)
Authors: Tseng C.-C.; Usdin T.; Wolfe M.

Prohormone processing enzymes in G-cells of the rat antral mucosa.
pp. 195-195(1)
Authors: Vaillant C.; Macro J.; Varro A.; Dockray G.J.; Dimaline R.; Seidah N.

c-AMP mediates neuropeptide and sympathetic modulation of IL-6 secretion by intestinal smooth muscle.
pp. 195-195(1)
Authors: Assche G.V.; Deng Y.; Gauldie J.; Peeters T.L.; Collins S.M.

Functional and immunocytochemical evidence that galanin is a physiological regulator of human jejunal motility.
pp. 196-196(1)
Authors: Varga G.; Feher E.; Balint A.; Kisfalvi I.; Mate M.; Ihasz M.; Vizi E.S.

Biosynthesis, processing and differential secretion of progastrin-derived peptides in human antral mucosa, in vitro.
pp. 196-196(1)
Authors: Varro A.; Dockray G.J.; Higham A.D.; Armitage E.; Thompson D.G.

Regulation of gastrin processing by intragranular biogenic amines
pp. 197-197(1)
Authors: Varro A.; Voronina S.; Dockray G.J.

VIP, PHM-27 and PreproPACAP derived peptides in neuroblastomas and ganglioneuromas
pp. 197-197(1)
Authors: Vedin I.; Bjellerup P.; Theodorsson E.; Kogner P.

Direct analysis of the peptide content of neuroendocrine tissue by MALDI-TOF mass spectrometry
pp. 198-198(1)
Authors: Verhaert P.; De Loof A.

The anorexic effect of jojoba and simmondsin in rats and chickens: a comparative study
pp. 198-198(1)
Authors: Vermaut S.; Cokelaere M.; Flo G.; Decuypere E.

PACAP/VIP receptors subtypes in rat pituitary gland and tumours
pp. 199-199(1)
Authors: Vertongen P.; Delhase M.; Rajas F.; Trouillas J.; Hooghe-Peters E.; Svoboda M.; Robberecht P.

Chronic intestinal pseudo-obstruction syndrome in two patients with pancreatic somatostatinoma
pp. 199-199(1)
Authors: Vezzadini C.; Bazzocchi G.; Poggioli R.; Conti E.; Anagni M.; Vezzadini P.

Regulation peptides in patients with esophague and duodenum diseases
pp. 200-200(1)
Authors: Vinnitsky L.I.; Poroykova M.V.

Exogenous Epidermal Growth Factor (EGF) Treatment Causes Time-dependent Increases in Renal Endogenous EGF Content and Excretion and a Time-dependent Decrease in the Endogenous EGF Content of the Submandibular Glands
pp. 200-200(1)
Authors: Vinter-Jensen L.; Jorgensen P.E.; Poulsen S.S.; Nexo E.

Chronic Systemic Treatment with Epidermal Growth Factor in Pigs Induces Ductal Proliferations in the Pancreas with Accumulation of Glycoconjugates.
pp. 201-201(1)
Authors: Vinter-Jensen L.; Juhl C.O.; Teglbjaerg P.S.; Poulsen S.S.; Dajani E.Z.; Nexo E.

Determination of amino acids in blood serum of patient with hepatic diseases
pp. 201-201(1)
Authors: Voroneckiene V.; Kucinskiene Z.

Evidence of VIP and NPY receptors in a human mast cell line.
pp. 202-202(1)
Authors: Wagner S.; Klaffschenkel R.A.; Becker H.D.; Williams R.M.

The peroxysomproliferator ciprofibrate induces hypergastrinemia without inhibiting gastric acid secretion
pp. 202-202(1)
Authors: Waldum H.; Martinsen T.; Sandvik A.

Ontogeny of somatostatin and opioid peptides in anencephlic human fetus gut and pancreas
pp. 203-203(1)
Authors: B M.W.; W T.L.; N X.H.; B H.D.; L W.; X Q.H.

Expression of the trefoil peptide, pS2, immunoreactivity in human neuroendocrine tumours
pp. 203-203(1)
Authors: Da-Gong W.; Johnston C.F.; Sloan J.M.; Buchanan K.D.

Vasoactive intestinal peptide (VIP) inhibits interleukin-4 production in antigen stimulated T lymphocytes.
pp. 204-204(1)
Authors: Hong-Ying W.; Zhicheng X.; Hao T.; Ganea D.

Possible role of hypothalamic nitric oxide in central somatostatin analog- and bombesin- induced inhibition of gastric acid secretion
pp. 204-204(1)
Authors: Wang L.; Coskun T.; Martinez V.; Tache Y.

Nitric oxide contributes to endotoxin-induced ocular inflammation: Interaction with sensory nerve fibres
pp. 205-205(1)
Authors: Zun-Yi W.; Alm P.; Hakanson R.

Release of preprotachykinin-A mRNA from rabbit iris upon C-fibre stimulation
pp. 205-205(1)
Authors: Z-Y. W.; Monstein H.-J.; Hakanson R.

SST-2 gene expression appears during human angiogenesis.
pp. 206-206(1)
Authors: Watson J.C.; Alperin-Lea R.C.; Redmann J.G.; Gebhardt B.M.; Woltering E.A.

The promoter of the murine gastrin-releasing peptide receptor (mGRP-R) gene can be regulated by cAMP in swiss 3T3 cells and harbours a silencing element.
pp. 206-206(1)
Authors: Weber H.C.; Battey J.F.; Jensen R.T.

Structure and chromosomal localization of the genes for the gastrin-releasing peptide receptor, neuromedin-B receptor and bombesin subtype 3 receptor.
pp. 207-207(1)
Authors: Weber H.C.; Hampton L.L.; Jensen R.T.; Battey J.F.

Changes in patterns of G-I hormone plasma levels in the young pig.
pp. 207-207(1)
Authors: Westrom B.R.; Pierzynowski S.G.; Karlsson S.; Ahren B.; Rehfeld J.; Olsen O.; Ekman R.; Karlsson B.

The effect of GLP-1 and PYY on acid secretion in man.
pp. 208-208(1)
Authors: Wettergren A.; Maina P.; Boesby S.; Holst J.

Gastrointestinal effects of GLP-1 and possibly mechanism of action.
pp. 208-208(1)
Authors: Wettergren A.; Wojdemann M.; Holst J.

The Extracellular Domain of the GLP-I Receptor is Essential for Ligand Binding and Shows Intrinsic Binding Activity
pp. 209-209(1)
Authors: Wilmen A.; van Eyll B.; Goke R.; Goke B.

Deficient gastric lipase secretion in pancreatic insufficiency.
pp. 209-209(1)
Authors: Wojdemann M.; Olsen O.; Larsen S.; Sternby B.; Rehfeld J.

Development of biologically active multi-iodinated somatostatin analogs
pp. 210-210(1)
Authors: Woltering E.A.; Murphy W.; O'Dorisio M.S.; Coy D.; Drouant G.; de la Claire J.F.; F. C.; Espenan G.; O'Dorisio T.M.

First intracellular loop of CCK-A receptor is essential for cAMP response to CCK in transfected HEK-293 cells
pp. 210-210(1)
Authors: S. V.W.; M. Y.; Seensalu R.; McRoberts J.; Walsh J.H.

Gastrin Releasing Peptide-like Immunoreactivity (GRPLI) in Human Pregnancy.
pp. 211-211(1)
Authors: Q. X.; Challis J.R.G.; X. H.; Spindel E.R.; Prasad C.; Hill D.; McDonald T.J.

Influence of Prandial State on the Gene Expression of Gastrin, Cholecystokinin, Somatostatin, Actin, GAPDH, 18S and 28S rRNA in the Pancreas and Upper Digestive Tract of Rats.
pp. 211-211(1)
Authors: Yamada H.; Nylander A.-G.; Chen D.; Kimura K.; Monstein H.-J.

Involvement of 5-HT₃, 5-HT₄ receptors on the motor activity of rat duodenum
pp. 212-212(1)
Authors: Yamamoto I.; Kuwahara A.; Fujimura M.; Kadowaki M.; Fujimiya M.

Measurement of surface electrical activity on small intestine and plasma cholecystokinin concentrations in patients with irritable bowel syndrome.
pp. 212-212(1)
Authors: Yun-sheng Y.; Wan-dai Z.; Yu-gang S.; Dian-yuan Z.

Signalling mechanism activated by gastrin in colonic epithelial cells.
pp. 213-213(1)
Author: Yassin R.R.

Intraduodenal administration of cholecystokinin-A receptor blocker (tarazepide) reduces secretion of pancreatic juice in newborn calves
pp. 213-213(1)
Authors: Zabielski R.; Lesniewska V.; Kiela P.; Gregory P.; Pierzynowski S.

Structural and functional diversity of endogenous regulatory oligopeptides
pp. 214-214(1)
Author: Zamyatnin A.A.

Cholecystokinin regulates somatostatin secretion through both the CCK-A and CCK-B/gastrin receptors
pp. 214-214(1)
Authors: Zavros Y.; Shulkes A.

Abnormal plasma gastrin levels, disturbed antral myoelectric activities and impaired gastric emptying in patients with bile reflux gastritis.
pp. 215-215(1)
Authors: Jin-Zhang Z.; Wan-Dai Z.; Wu-He P.; Xue-qing C.; Zhen-Shu Z.; Dian-Yan Z.

Expression of Gastrin, Histamine H₂ and Muscarinic acetylcholic Receptor Gene in Rat Gastric Mucosa.
pp. 215-215(1)
Authors: Wan-dai Z.; Xue-qing C.; Tian-mo W.; Yu-gang S.; Dian-yuan Z.

Pituitary adenylate cyclase activating peptide (PACAP) is involved in inflammation and inflammation evoked nociceptive transmission.
pp. 216-216(1)
Authors: Y-Z. Z.; Malmberg A.B.; Yaksh T.L.; Sjolund B.; Overgaard L.; Bjursten L.M.; Danielsen N.; Sundler F.

Orphanin FQ/nociceptin and its mRNA in rat spinal cord
pp. 216-216(1)
Authors: Y-Z. Z.; Mulder H.; J-K. C.; Danielsen N.; Sundler F.

Effect of -Fluoromethylhistidine-evoked Histamine Depletion on Ultrastructure of Endocrine Cells in Acid-producing Mucosa of Stomach in Mouse, Rat and Hamster
pp. 217-217(1)
Authors: Chun-Mei Z.; Andersson K.; Duan C.; Sundler F.; Hakanson R.

Increased number of secretory granules and lipofucsin-containing lysosomes in rat stomach ECL cells after omeprazole treatment
pp. 217-217(1)
Authors: Chun-Mei Z.; Duan C.; Kimura K.; Hakanson R.

Structural motifs of pituitary adenylate cyclase activating polypeptide (PACAP) defining PACAP/VIP type-1 (PV1) receptor selectivity
pp. 218-218(1)
Authors: Jie Z.; Schafer H.; Morys-Wortmann C.; Schmidt W.E.

Behavioural, autonomic and endocrine responses associated with C-fos expression in the forebrain and brain stem after intracereventricular infusions of endothelins
pp. 218-218(1)
Authors: Zhu B.; Herbert J.

Increased blood levels of 5-hydroxytryptamine in coeliac disease.
pp. 219-219(1)
Authors: Zoli G.; Corazza G.R.; Parazza M.; Care M.; Gasbarrini G.

Hypergastrinemia is associated with helicobacter pylori infective load in duodenal ulcer patients.
pp. 219-219(1)
Authors: Zverkov I.V.; Isakov V.A.

Gastrointestinal peptides and endocrine cells in peptic ulcer disease.
pp. 220-220(1)
Authors: Zverkov I.V.; Minushkin O.N.